Drug coverage is limited to prescription products approved by the Food and Drug Administration as evidenced by a New Drug Application (NDA), Abbreviated New Drug Application (ANDA), or Biologics Licensed Application (BLA) on file. Any legal requirements or group specific benefits for coverage will supersede this (e.g. preventive drugs per the Affordable Care Act).


Drug coverage may also be subject to policy guidelines established by Blue Cross and Blue Shield of Alabama. Drug coverage policies are not intended to dictate to physicians how to practice medicine. Physicians should exercise their medical judgment in providing the care they feel is most appropriate for their patients.


Please note: Some employer groups may have specific drug coverage requirements for their employees that are not included in the criteria below.

Drug Coverage Guidelines

Search by Drug Name

Product Name Guideline Coverage Benefit* Implementation Date Change Date
TAFINLAR® Prior authorization for medical necessity is required. The limits are 4 capsules per day. P 01/01/14
TAGRISSO Prior authorization for medical necessity is required. Limits are 30 tablets per 30 days. P 11/25/15 01/01/16
TAKHZYRO Prior authorization for medical necessity is required. The limits are 4 mls every 28 days. M 08/23/18 01/01/19
TALACEN The limits are 6 tablets per day. P 04/01/12 01/01/18
TALTZ™ Prior authorization for medical necessity is required. The limits are 1 syringe per 28 days. P 04/15/16 01/01/18
TALZENNA Prior authorization for medical necessity is required. The limits for 0.25mg are 3 capsules per day and 1 capsule per day for 1 mg. P 01/01/19
TAMIFLU® The limits are 20 capsules per 120 days, and 360 mL for 6 mg/mL and 150 mL for 12 mg/mL strengths per 120 days . P 02/01/05 10/01/16
TANZEUM® Tanzeum may be subject to step therapy requirements. Patients must have trial and failure of one or more of the following antidiabetic agents: metformin, sulfonylurea, combinations of metformin or sulfonylureas, or basal insulin (Lantus or Levemir). The limits are 4 vials per 28 days. P 10/01/14
TARCEVA® Prior authorization for medical necessity is required. The limits are 1 tablet per day, except 25mg tablets with a limit of 2 tablets per day. P 03/14/07 07/01/11
TARGADOX Targadox may be subject to step therapy requirements. Patients must have trial and failure of generic immediate release doxycycline AND generic immediate release minocycline. P 04/01/18
TARGRETIN Prior authorization for medical necessity is required. P 04/01/18
TASIGNA® Prior authorization for medical necessity is required. The limits are 4 capsules per day. P 04/01/11
TAVABORALE Prior authorization for medical necessity is required. The limits are 4 ml per 30 days. P 07/01/16
TAZORAC® Prior authorization for medical necessity may be required. P 04/01/01
TECENTRIQ Prior authorization for medical necessity is required. M 12/01/16